Affordable Access

Determination of fibrinogen in normal human plasma in the presence and absence of anticoagulants

Journal of Laboratory and Clinical Medicine
Publication Date
  • Laboratory Methods
  • Biology


Abstract A method, independent of cloning, and using the highly specific precipitant of fibrinogen, potassium mercuric thiocyanate [K 2Hg(CNS) 4], is described for determining the fibrinogen content of human plasmas that clot normally upon the addition of thrombin or of human plasmas with added heparin or Pyran (divinyl ether-maleic acid copolymer) that do not clot or clot abnormally when thrombin is added. The plasma is mixed with phosphate buffer, pH 7.4, 6-aminocaproic acid, NaCl, and K 2Hg(CNS) 4 and the protein content of the precipitated fibrinogen is determined. After washing and dissolving, the fibrinogen precipitated by the thiocyanate salt clots normally when thrombin is added. However, if either haparin or Pyran is present during the precipitation step, normal clots do not form when thrombin is added. These data confirm the results of other investigators who showed that the thiocyanate reagent does not change the clottability of fibrinogen and that both heparin and Pyran change fibrinogen so that normal clots do not form.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Determination of fibrinogen in normal human plasma...

on Journal of Laboratory and Clin... November 1973

Determination of normal values of plasma fibrinoge...

on Journal of the Indian Medical... Feb 01, 1970

[Determination of fibrinogen in human plasma using...

on Das Medizinische Laboratorium November 1981
More articles like this..